Lower Drug Prices: Global Benchmarking and Personal Importation
This bill aims to reduce prescription drug prices in the U.S. by aligning them with international benchmarks. It also facilitates individual importation of drugs, potentially saving patients money. Authorities will also target anti-competitive practices by drug manufacturers.
Key points
U.S. drug prices are to be compared with those in other developed countries to potentially lower costs for patients.
Individuals may be able to import cheaper prescription drugs from other developed countries, if deemed safe.
Authorities will take action against drug manufacturers engaging in anti-competitive practices.
Introduced
Citizen Poll